Bladder cancer in women

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Nicholson, Brian D ^a   McGrath, John S ^b,c   Hamilton, Willie ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER CLASSIFICATION; CLINICAL FEATURE; DYSURIA; HEMATURIA; HUMAN; MANAGED CARE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYMPTOM ASSESSMENT; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINARY FREQUENCY;

DIAGNOSTIC ERRORS; FEMALE; HEMATURIA; HUMANS; MALE; SEX FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84898002795     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2171     Document Type: Review

References (15)

1. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374:239-49.
2. Lunt CR, Maddineni SB, Brough R. Bladder cancer. Br J Med Surg Urol 2012;5:95-103.
3. Shephard EA, Stapley S, Neal RD, Rose P, Walter FM, Hamilton WT. Clinical features of bladder cancer in primary care. Br J Gen Pract 2012;62:e598-604.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
5. Bladder cancer. Cancer Research UK, 2013. www.cancerresearchuk.org/ cancer-help/type/bladder-cancer/
6. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 2013;3:e002861.
7. Allaby M. Screening for bladder cancer using the urinalysis/dipstick method: a report for the national screening committee. NHS, 2010. www.screening.nhs.uk/policydb-download.php?doc=62
8. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria. Cancer 2013;120:555-61.
9. Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 2013;112:68-73.
10. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011;29:457-63.
11. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010;105:300-8.
12. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S, on behalf of the West Midlands Urological Research Group. Delay and survival in bladder cancer. BJU Int 2002;89:868-78. (Pubitemid 34535418)
13. NICE. Referral for suspected cancer (CG27). National Institute for Health and Care Excellence, 2005.
14. Hippisley-Cox J, Coupland C. Identifying patients with suspected renal tract cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2012;62:e251-60.
15. Planz B, Jochims E, Deix T, Caspers HP, Jakse G, Boecking A. The role of urinary cytology for detection of bladder cancer. Eur J Surg Oncol 2005;31:304-8. (Pubitemid 40361523)